Concepedia

Maria Alba

MA

Statistics

Publications

36

Citations

3.2K

H-Index

24

Active since

1985

Affiliations

Janssen (United States)(Current)

Johns Hopkins University

Johns Hopkins Medicine

Merck & Co., Inc., Rahway, NJ, USA (United States)

Janssen Scientific Affairs (United States)

Maria Alba is an author at Janssen (United States) specializing in medicine, diabetes mellitus, and pharmacology.

ORCID

Publications per year

1985–2021

36

Publications

36

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

Kaj Stenlöf, William T. Cefalu, Kyung‐Ah Kim et al. · Diabetes Obesity and Metabolism · 2012 · 611 citations · Full text

, , +17

Efficacy and Safety of Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes

Robert R. Henry, Payal Thakkar, Cindy S.W. Tong et al. · Diabetes Care · 2015 · 288 citations

, , +17

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

Itamar Raz, Yu Chen, Mei Wu et al. · Current Medical Research and Opinion · 2008 · 262 citations

, , +16

Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes

Bruce Neal, Vlado Perkovic, Dick de Zeeuw et al. · Diabetes Care · 2014 · 236 citations

, , +17

Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes

Gary Meininger, Russell Scott, Maria Alba et al. · Diabetes Care · 2011 · 217 citations · Full text

, , +13

1–5 of 36